United States · Series C startup

Who invested in Colossal Biosciences

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechClimate TechEngineeringGenomics

Raised 9 months agoValuation: $1.0B, Oct 2024

Funding summaryUpdated 5 Nov 2026

$380Mraised across 3 rounds since 2025, from 5 sources

$200MSeries C$120MSeries C$60MSeries C
Latest round
Series C, $60MFeb 2026
Biggest round
$200MSeries C · Jan 2025
Investors
5 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$200MSeries C$120MSeries C$60MSeries C
First round
Series C, $200M
Jan 2025
Biggest round
$200M
Series C · Jan 2025
Usual gap between rounds
8 months
the median of 2

The rounds

  1. Feb 2026
    Series C$60M4 new

    Also list them on their own siteShane Neman

    Source recorded

  2. Sept 2025
    Series C$120M1 returning

    Reported by TechStartups

  3. Jan 2025
    Series C$200M1 new

    Also list them on their own siteMaiora Ventures

    Reported by Crunchbase News and 2 others

Funding filed with regulators

Colossal Biosciences filed one raise, $163M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Jan 2023$163M27 investorsof $174M offeredSEC Form D

Founders and team

From Colossal Biosciences's own website: 8 on the team.

  • Chris KleeExecutive Vice President, Marketing & Design
  • Michael DoughertyExecutive Vice President - Creative Entertainment
  • Andrew BuseyChief Product Officer
  • Regulatory Affairs LeadChief Science Officer
  • Sarah GrantChief Of Staff
  • Amanda BastawrosHead of HR
  • Jillian McCallMarketing Director
  • Sara OrdDirector of Biotechnology Innovation

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

TWG GlobalGrowth equity2rounds, led 2
Liquid 2 VenturesVC firm1round
Draper AssociatesVC firm1round
Builders VCVC firm1round
At One VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 11 firms list Colossal Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Winklevoss CapitalFamily officePer its own site
Breyer CapitalPrivate equityPer its own site
Jazz Venture PartnersVC firmPer its own site
JuniperVC firmPer its own site
Maiora VenturesVC firm2025, per its site
SUPERNOVAVC firmPer its own site
Shane NemanAngel2026, per its site
Carnrite VenturesVC firmPer its own site
Founder WorksVC firmPer its own site
Mancora VenturesVC firmPer its own site
Peter H. Diamandis (PHD Ventures)Family officePer its own site

Quick answers about Colossal Biosciences

Who invested in Colossal Biosciences?

Colossal Biosciences's investors include TWG Global, Liquid 2 Ventures, Draper Associates, Builders VC and At One Ventures.

How much has Colossal Biosciences raised?

Colossal Biosciences has raised $380M across 3 rounds since 2025.

When did Colossal Biosciences last raise?

Colossal Biosciences's most recent round was a Series C of $60M in Feb 2026.

What was Colossal Biosciences's biggest round?

Colossal Biosciences's largest round on record is $200M (Series C), in Jan 2025, led by TWG Global.

Who backed Colossal Biosciences first?

Colossal Biosciences's first round on record, in Jan 2025, was backed by TWG Global.

What stage is Colossal Biosciences at?

Colossal Biosciences's latest named round is a Series C, in Feb 2026.

Where is Colossal Biosciences based?

Colossal Biosciences is based in the United States.

Who led Colossal Biosciences's rounds?

TWG Global led the Series C in 2025.

Companies like Colossal Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.